Skip to main content
. 2020 Mar 5;12(3):599. doi: 10.3390/cancers12030599

Figure 5.

Figure 5

Glutaminase-1 (GLS-1) expression of PC12 and HeLa cells upon SDH inhibition: all values are normalized to control. (A) Fold changes in GLS-1 expression in PC12 cells upon Sdhb knockdown, itaconate treatment, and atpenin treatment. (B) Fold changes in GLS-1 expression in HeLa cells upon itaconate and atpenin treatment. (C) Fold changes in GLS-1 expression in H295R cells upon itaconate and atpenin treatment. Ita: itaconate; i-veh: control for itaconate experiments; a-veh: control for atpenin experiments; *: p < 0.05; **: p < 0.01.